JAZZ PDUFA Date: Cannabidiol oral

Name: Cannabidiol oral FDA decision
Start: 2027-04-16
End: 2027-04-16

Page updated November 5, 2026·next FDA decision on the calendar ·Data as of Nov 5, 2026 5:03 AM ET

FDA decision (PDUFA) target Apr 16, 2027 · Jazz Pharmaceuticals plc · Oral cannabidiol capsule formulation

Source: Jazz 8-K 2026-11-02 (EX-99.1, Q3 2026 results). “The PDUFA target action date for our New Drug Application (NDA) for the oral cannabidiol capsule formulation is April 16, 2027.”

Key facts

FDA PDUFA target date2027-04-16

Drug / candidateCannabidiol oral

IndicationOral cannabidiol capsule formulation

CompanyJazz Pharmaceuticals plc

Market-cap tierLarge

New to FDA decisions? Read what a PDUFA date is and how often the FDA approves drugs.

See every 2027 PDUFA date →All April 2027 PDUFA dates →

FAQ

When is the JAZZ PDUFA date?

The FDA PDUFA target date for JAZZ (Jazz Pharmaceuticals plc) is 2027-04-16 for Cannabidiol oral. Dates are company/FDA-sourced and can slip. Verify against primary filings.

What is JAZZ's drug Cannabidiol oral?

Cannabidiol oral is Jazz Pharmaceuticals plc's candidate under FDA review for Oral cannabidiol capsule formulation.